We use cookies on our site to analyze traffic, enchance your experience, and provide you with tailored content. For full functionality of this site, you must consent to the use of cookies. For more information or to opt out, visit our privacy policy.
News& Insight
We're getting results - and making headlinesWatch this space to keep up with breaking headlines and stay current with cutting edge trends relating to complex litigation and arbitration matters.
A proposed class of AbbVie Inc. investors filed a stock drop suit against the pharmaceutical company in Illinois federal court Thursday, saying a corrective disclosure related to the company’s May stock buyback efforts led to a collective $100 million loss in value for the shareholders.